Lana E. Kandalaft

Lana E. Kandalaft publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lana E. Kandalaft sits on this spectrum.

Lana E. Kandalaft D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lana E. Kandalaft sits on this spectrum.

Best Publications

• Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors

  Denarda Dangaj;Marine Bruand;Alizée J. Grimm;Catherine Ronet

  844
  Citations

• Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

  Janos L. Tanyi;Sara Bobisse;Eran Ophir;Sandra Tuyaerts

  427
  Citations

• Whole Tumor Antigen Vaccines: Where Are We?

  Cheryl Lai-Lai Chiang;George Coukos;George Coukos;Lana E. Kandalaft;Lana E. Kandalaft

  339
  Citations

• T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.

  Natalie J. Neubert;Martina Schmittnaegel;Natacha Bordry;Sina Nassiri

  295
  Citations

• Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity.

  Michal Bassani-Sternberg;Chloé Chong;Chloé Chong;Philippe Guillaume;Philippe Guillaume;Marthe Solleder;Marthe Solleder

  285
  Citations

• Antitumour dendritic cell vaccination in a priming and boosting approach

  Alexandre Harari;Alexandre Harari;Michele Graciotti;Michele Graciotti;Michal Bassani-Sternberg;Michal Bassani-Sternberg;Lana E Kandalaft;Lana E Kandalaft

  252
  Citations

• Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis

  U Dafni;U Dafni;O Michielin;S Martin Lluesma;S Martin Lluesma;Z Tsourti

  241
  Citations

• A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

  Cheryl Lai-Lai Chiang;Lana E. Kandalaft;Janos Tanyi;Andrea R. Hagemann

  237
  Citations

• Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

  Beatris Mastelic-Gavillet;Blanca Navarro Rodrigo;Laure Décombaz;Haiping Wang

  204
  Citations

• Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results

  Unknown

  201
  Citations

• Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation

  Unknown

  200
  Citations

• Immunotherapy for Ovarian Cancer: What's Next?

  Lana E. Kandalaft;Daniel J. Powell;Nathan Singh;George Coukos

  189
  Citations

• The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

  Kalijn F. Bol;Gerty Schreibelt;Katrin Rabold;Stefanie K. Wculek

  179
  Citations

• Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer

  Lana E. Kandalaft;Daniel J. Powell;Cheryl L. Chiang;Janos Tanyi

  179
  Citations

• Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.

  Jaikumar Duraiswamy;Riccardo Turrini;Aspram Minasyan;David Barras

  179
  Citations

• Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer.

  Sara Bobisse;Raphael Genolet;Annalisa Roberti;Janos L. Tanyi

  160
  Citations

• Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGFβ.

  Markus Germann;Nadine Zangger;Nadine Zangger;Nadine Zangger;Marc-Olivier Sauvain;Christine Sempoux

  157
  Citations

• A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer.

  Lana E Kandalaft;Daniel J Powell;George Coukos

  156
  Citations

• Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines

  Cheryl Lai-Lai Chiang;Lana E. Kandalaft;George Coukos

  146
  Citations

• Rational combinations of immunotherapy with radiotherapy in ovarian cancer

  Fernanda G Herrera;Fernanda G Herrera;Melita Irving;Lana E Kandalaft;Lana E Kandalaft;George Coukos;George Coukos

  136
  Citations